Search results
Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Yahoo News UK· 2 days agoRees-Mogg suggested that a major problem was that the nature of the rollout had encouraged...
Destiny 2: The Final Shape Is Changing How Some Of Its Bounties Work
Kotaku· 1 day agoDestiny bounty preppers are shaking in their boots
To Address the Mental Health Crisis, Look to School Nurses
Time Magazine· 4 days agoThere are already people on the front lines to combat this teen mental health crisis: school nurses,...
National Bank of Canada FI Acquires 32,861 Shares of Southwest Airlines Co. (NYSE:LUV)
ETF DAILY NEWS· 1 day agoNational Bank of Canada FI raised its holdings in shares of Southwest Airlines Co. (NYSE:LUV – Free...
Why Remote Work Is Incompatible With A Company's Long Term Growth
Forbes· 4 days agoTech giants around the globe are pushing or pulling employees to return to the office. Strategies...
Webster Financial Co. (NYSE:WBS) Receives $56.23 Average Price Target from Brokerages
ETF DAILY NEWS· 5 hours agoWebster Financial Co. (NYSE:WBS – Get Free Report) has received an average recommendation of...
Hillenbrand, Inc. (NYSE:HI) VP Purchases $37,890.00 in Stock
ETF DAILY NEWS· 3 days agoHillenbrand, Inc. (NYSE:HI – Get Free Report) VP Leo Kulmaczewski acquired 900 shares of Hillenbrand stock in a transaction on Friday, May 3rd. The shares were purchased at an average cost of ...
Here’s what sociologists want you to know about teen suicide
Vox· 5 days agoBetween 2000 and 2015 in an affluent, predominately white community in the US, 19 young people died...
Xbox’s Shift To ‘High-Impact’ Games Is Misguided At Best, Reckless At Worst
Kotaku· 3 days agoEarlier this week, Xbox announced that it would be shuttering several studios it had attained as...
Leerink Partnrs Weighs in on Pliant Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:PLRX)
ETF DAILY NEWS· 1 day agoPliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) – Leerink Partnrs raised their Q2 2024 earnings per share (EPS) estimates for Pliant Therapeutics in a research note issued to investors ...